MX2021000776A - Usos de composiciones de curcuminoides. - Google Patents

Usos de composiciones de curcuminoides.

Info

Publication number
MX2021000776A
MX2021000776A MX2021000776A MX2021000776A MX2021000776A MX 2021000776 A MX2021000776 A MX 2021000776A MX 2021000776 A MX2021000776 A MX 2021000776A MX 2021000776 A MX2021000776 A MX 2021000776A MX 2021000776 A MX2021000776 A MX 2021000776A
Authority
MX
Mexico
Prior art keywords
compositions
curcuminoid compositions
curcuminoid
methods
bioaccessibility
Prior art date
Application number
MX2021000776A
Other languages
English (en)
Inventor
Pascale Elizabeth Renée Fança-Berthon
Simona Birtic
Leila Denise Falcao
Mathieu Tenon
Maryline Vinal
Original Assignee
Naturex Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1812776.1A external-priority patent/GB201812776D0/en
Priority claimed from GBGB1902266.4A external-priority patent/GB201902266D0/en
Application filed by Naturex Sa filed Critical Naturex Sa
Publication of MX2021000776A publication Critical patent/MX2021000776A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a métodos y usos de composiciones que comprenden curcumina; en particular, métodos y usos con relación a la mejora de la bioaccesibilidad, biodisponibilidad, bioeficacia y/o bioactividad de curcuminoides en mamíferos.
MX2021000776A 2018-08-06 2019-08-05 Usos de composiciones de curcuminoides. MX2021000776A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1812776.1A GB201812776D0 (en) 2018-08-06 2018-08-06 New methods and uses
GBGB1902266.4A GB201902266D0 (en) 2019-02-19 2019-02-19 New methods and uses
PCT/EP2019/071055 WO2020030612A1 (en) 2018-08-06 2019-08-05 Uses of curcuminoid compositions

Publications (1)

Publication Number Publication Date
MX2021000776A true MX2021000776A (es) 2021-06-15

Family

ID=67770463

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021000776A MX2021000776A (es) 2018-08-06 2019-08-05 Usos de composiciones de curcuminoides.

Country Status (10)

Country Link
US (2) US20220280448A1 (es)
EP (1) EP3833337A1 (es)
JP (1) JP2021534105A (es)
KR (1) KR20210041037A (es)
CN (1) CN112566630A (es)
AU (1) AU2019320488A1 (es)
BR (1) BR112021001403A2 (es)
CA (1) CA3108123A1 (es)
MX (1) MX2021000776A (es)
WO (1) WO2020030612A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113208109B (zh) * 2021-04-30 2023-08-29 河南中大恒源生物科技股份有限公司 一种高生物利用度水溶姜黄素及其制备方法以及应用
CN113383881B (zh) * 2021-04-30 2023-08-29 河南中大恒源生物科技股份有限公司 一种液体水溶姜黄素及其制备方法以及应用
CN115028886B (zh) * 2022-06-21 2023-11-21 贺州学院 一种用于检测铅离子的双去甲氧基姜黄素显色薄膜、其制备方法和铅离子快速检测方法
WO2024041724A1 (en) * 2022-08-22 2024-02-29 Givaudan Sa Composition comprising curcuminoids, modified starch and/or acacia gum and saponins for use as a medicament

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5448511B2 (ja) * 2008-03-31 2014-03-19 三栄源エフ・エフ・アイ株式会社 ウコン色素組成物及びその調製方法
EP2359702B1 (en) * 2010-01-22 2014-06-04 Symrise AG Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
JP5938587B2 (ja) * 2011-01-31 2016-06-22 株式会社シクロケムバイオ 脂溶性物質を含む水溶液の製造方法
DE102011056111B4 (de) * 2011-12-06 2013-08-14 Sensient Colors Europe Gmbh Emulsion
DK2721933T3 (da) * 2012-10-16 2017-11-20 DÖHLER GmbH Emulsion
BR112015029759A2 (pt) * 2013-06-21 2017-07-25 Firmenich & Cie preparação de partículas secas que compreendem mentol
EP3035947A4 (en) * 2013-08-19 2018-09-26 Aurea Biolabs Private Limited A novel composition of curcumin with enhanced bioavailability
US10016363B2 (en) * 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
CN109219639B (zh) * 2016-04-01 2021-04-06 三荣源有限公司 稳定固体色素的方法
CN109788789A (zh) * 2016-09-26 2019-05-21 三荣源有限公司 姜黄素组合物
WO2018083677A1 (en) * 2016-11-07 2018-05-11 Akay Flavours & Aromatics Pvt. Ltd. Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof

Also Published As

Publication number Publication date
WO2020030612A1 (en) 2020-02-13
EP3833337A1 (en) 2021-06-16
CA3108123A1 (en) 2020-02-13
US20240115519A1 (en) 2024-04-11
AU2019320488A1 (en) 2021-02-18
KR20210041037A (ko) 2021-04-14
CN112566630A (zh) 2021-03-26
JP2021534105A (ja) 2021-12-09
BR112021001403A2 (pt) 2021-04-27
US20220280448A1 (en) 2022-09-08

Similar Documents

Publication Publication Date Title
MX2021000776A (es) Usos de composiciones de curcuminoides.
PH12020550051A1 (en) Glp-1 compositions and uses thereof
WO2018229236A3 (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
WO2017095944A8 (en) Methods and compositions relating to chondrisomes from blood products
WO2017106346A3 (en) Human immunodeficiency virus neutralizing antibodies
WO2016170348A8 (en) Sarna compositions and methods of use
CN107397757A8 (zh) 润滑剂制剂
WO2019123015A8 (en) Lysophosphatidylcholine compositions
WO2015061798A3 (en) Compositions and methods comprising yeast organisms and lipid extracts thereof
EP3445782A4 (en) H1.0 DIMETHYLATED K180 PROTEIN COMPOSITIONS AND METHODS
WO2017136450A3 (en) Compounds and methods of treating rna-mediated diseases
MX2020001885A (es) Formulaciones de daptomicina.
MX2017012207A (es) Derivados de aceite natural maleatado a manera de ingredientes agroquimicos inertes.
PH12020551716A1 (en) Anti-ror antibody constructs
MX367669B (es) Compuestos antiproliferativos y sus composiciones farmacéuticas y usos.
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
MX2020008125A (es) Composiciones que comprenden berberina.
WO2016020210A8 (en) Factor viii formulation
MX2021000774A (es) Composiciones de curcuminoides.
WO2016056026A3 (en) Synergistic composition for osteoarthritis
WO2016100615A3 (en) Methods and composition for neutralization of influenza
EP3539978A4 (en) NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION WITH IT AS THE ACTIVE INGREDIENT
WO2017123610A3 (en) Bacteria engineered to detoxify deleterious molecules
WO2017075171A3 (en) Pamam dendrimer based cest imaging agents and uses thereof
WO2016109853A3 (en) Dietary supplement compositions